Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical Lung Cancer|December 17, 2008
Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancerHeather Wakelee, Kemp Kernstine, Everett Vokes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumorsPatricia M Lorusso, Antonio Jimeno, Grace Dy, et al.
Clinical Lung Cancer|August 6, 2013
Prospective observational comparison of clinical outcomes between african-american and caucasian patients receiving second-line treatment with pemetrexed for advanced non-small-cell lung cancerEduardo Pennella, Coleman K Obasaju, Gerhardt Pohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerMatthew P Goetz, David Toft, Joel Reid, et al.
International Journal of Radiation Oncology, Biology, Physics|May 30, 2006
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancerSteven E Schild, William L McGinnis, David Graham, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 19, 2013
Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expressionChukwumere E Nwogu, Sai Yendamuri, Wei Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptorJohann S de Bono, Gerhardt Attard, Alex Adjei, et al.
Clinical Lung Cancer|November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer CongressHeather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Investigational New Drugs|July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
Investigational New Drugs|September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignanciesJoleen M Hubbard, Jun Yin, Erin L Schenk, et al.
Pageof 4